Vivos Therapeutics, Inc. (VVOS)
0.1206
0.00 (0.00%)
USD |
NASDAQ |
Oct 29, 16:00
0.115
-0.01
(-4.64%)
After-Hours: 07:53
Vivos Therapeutics Enterprise Value : 13.42M for Oct. 29, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 29, 2026 | 13.42M |
| October 28, 2026 | 13.44M |
| October 27, 2026 | 13.53M |
| October 26, 2026 | 13.57M |
| October 23, 2026 | 13.61M |
| October 22, 2026 | 13.59M |
| October 21, 2026 | 13.62M |
| October 20, 2026 | 13.71M |
| October 19, 2026 | 13.63M |
| October 16, 2026 | 13.57M |
| October 15, 2026 | 13.74M |
| October 14, 2026 | 13.61M |
| October 13, 2026 | 13.72M |
| October 12, 2026 | 13.76M |
| October 09, 2026 | 13.83M |
| October 08, 2026 | 13.84M |
| October 07, 2026 | 13.86M |
| October 06, 2026 | 13.90M |
| October 05, 2026 | 13.90M |
| October 02, 2026 | 13.87M |
| October 01, 2026 | 13.83M |
| September 30, 2026 | 13.81M |
| September 29, 2026 | 13.85M |
| September 28, 2026 | 13.61M |
| September 25, 2026 | 13.71M |
| Date | Value |
|---|---|
| September 24, 2026 | 13.78M |
| September 23, 2026 | 13.83M |
| September 22, 2026 | 13.94M |
| September 21, 2026 | 13.99M |
| September 18, 2026 | 14.04M |
| September 17, 2026 | 14.22M |
| September 16, 2026 | 14.01M |
| September 15, 2026 | 14.04M |
| September 14, 2026 | 14.23M |
| September 11, 2026 | 14.34M |
| September 10, 2026 | 14.30M |
| September 09, 2026 | 14.14M |
| September 08, 2026 | 14.28M |
| September 04, 2026 | 14.37M |
| September 03, 2026 | 14.20M |
| September 02, 2026 | 14.17M |
| September 01, 2026 | 14.12M |
| August 31, 2026 | 14.51M |
| August 28, 2026 | 14.93M |
| August 27, 2026 | 15.42M |
| August 26, 2026 | 15.35M |
| August 25, 2026 | 15.52M |
| August 24, 2026 | 15.69M |
| August 21, 2026 | 15.98M |
| August 20, 2026 | 15.72M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Hinge Health, Inc. | 8.992B |
| Exlites Holdings International, Inc. | 19.82M |
| Xcelerate, Inc. | 12.35M |
| Pro-Dex, Inc. | 205.86M |
| Autonomix Medical, Inc. | -2.354M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.523M |
| Revenue (Quarterly) | 5.153M |
| Total Expenses (Quarterly) | 10.63M |
| EPS Diluted (Quarterly) | -0.31 |
| Gross Profit Margin (Quarterly) | 47.41% |
| Profit Margin (Quarterly) | -107.2% |
| Earnings Yield | -1.72K% |
| Normalized Earnings Yield | -1726.12 |